PROVECA PHARMA LIMITED

Proveca Pharma Ltd is a global pharmaceutical company dedicated to developing and licensing medicines that meet the unmet medical needs of children. As a family of passionate pioneers, Proveca focuses on creating age‑appropriate, fully licensed paediatric formulations, recognising that many existing treatments are unsuitable for young patients or lack proper licensing.

The company’s current therapeutic specialisations lie in neurology and cardiology, where it is building an active pipeline of research‑driven medicines. By collaborating closely with clinicians, parents, carers and the children themselves, Proveca ensures that its products are tailored to the specific requirements of long‑term, chronic conditions. In addition to product development, the firm offers partnership opportunities for research and investment, and provides robust support for adverse‑event reporting and clinical trial transparency.

Proveca operates from key hubs in Manchester, United Kingdom, and Dublin, Ireland, positioning it to serve paediatric patients across Europe and beyond with a commitment to safety, innovation and compassionate care.